Khaled Sarsour

3.3k total citations
51 papers, 2.4k citations indexed

About

Khaled Sarsour is a scholar working on Rheumatology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khaled Sarsour has authored 51 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 10 papers in Psychiatry and Mental health and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khaled Sarsour's work include Rheumatoid Arthritis Research and Therapies (18 papers), Dementia and Cognitive Impairment Research (9 papers) and Systemic Lupus Erythematosus Research (8 papers). Khaled Sarsour is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Dementia and Cognitive Impairment Research (9 papers) and Systemic Lupus Erythematosus Research (8 papers). Khaled Sarsour collaborates with scholars based in United States, Switzerland and United Kingdom. Khaled Sarsour's co-authors include Douglas P. Jutte, Margaret A. Sheridan, Sara Gale, W. Thomas Boyce, Amani Nuru‐Jeter, Stephen P. Hinshaw, Pavel Napalkov, Kathleen A. Foley, Micki Klearman and Neil Collinson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Khaled Sarsour

49 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khaled Sarsour United States	27	682	469	358	355	346	51	2.4k
Michelle J. Naughton United States	37	275 0.4×	732 1.6×	277 0.8×	480 1.4×	244 0.7×	132	4.6k
Steven Hass United States	24	253 0.4×	156 0.3×	345 1.0×	134 0.4×	404 1.2×	65	3.1k
Hilary Watt United Kingdom	39	390 0.6×	294 0.6×	867 2.4×	76 0.2×	497 1.4×	93	5.4k
J. Fermanian France	32	377 0.6×	141 0.3×	560 1.6×	88 0.2×	457 1.3×	84	3.3k
Alicia C. Shillington United States	18	102 0.1×	913 1.9×	103 0.3×	1.1k 3.0×	223 0.6×	50	2.9k
Andreas Becker Germany	35	334 0.5×	1.3k 2.8×	971 2.7×	357 1.0×	1.9k 5.4×	216	5.4k
Faith Matcham United Kingdom	26	1.1k 1.5×	141 0.3×	574 1.6×	328 0.9×	419 1.2×	89	3.3k
Cindy J. Nowinski United States	25	78 0.1×	137 0.3×	681 1.9×	302 0.9×	377 1.1×	77	2.9k
Jerry C. Parker United States	36	1.1k 1.7×	211 0.4×	1.2k 3.4×	218 0.6×	410 1.2×	151	4.2k
Ali S. Khashan Ireland	42	239 0.4×	240 0.5×	389 1.1×	39 0.1×	640 1.8×	165	5.1k

Countries citing papers authored by Khaled Sarsour

Since Specialization

Citations

This map shows the geographic impact of Khaled Sarsour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Sarsour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Sarsour more than expected).

Fields of papers citing papers by Khaled Sarsour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled Sarsour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Sarsour. The network helps show where Khaled Sarsour may publish in the future.

Co-authorship network of co-authors of Khaled Sarsour

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Sarsour. A scholar is included among the top collaborators of Khaled Sarsour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Sarsour. Khaled Sarsour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ackerman, Benjamin, Ryan W. Gan, Craig S. Meyer, et al.. (2024). Measurement error and bias in real-world oncology endpoints when constructing external control arms. SHILAP Revista de lepidopterología. 4. 1423493–1423493. 1 indexed citations

Paul, Sanjoy K., Olga Montvida, Jennie H. Best, et al.. (2021). Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis. BMJ Open. 11(6). e042246–e042246. 3 indexed citations

Ascierto, Paolo A., Matthew H. Secrest, Peter Lambert, et al.. (2021). 1574P Mortality of 1,636 COVID-19 cancer patients (pts) and associated prognostic factors. Annals of Oncology. 32. S1137–S1138. 1 indexed citations

Gale, Sara, Katie Tuckwell, Neil Collinson, et al.. (2019). Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data. Rheumatology and Therapy. 6(1). 77–88. 22 indexed citations

Kim, Seoyoung C., Ajinkya Pawar, Rishi Desai, et al.. (2019). Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study. Seminars in Arthritis and Rheumatism. 49(2). 222–228. 40 indexed citations

Best, Jennie H., et al.. (2018). Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 45(3). 320–328. 26 indexed citations

Lauper, Kim, Dan Nordström, Karel Pavelká, et al.. (2018). Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. Annals of the Rheumatic Diseases. 77(9). 1276–1282. 49 indexed citations

Paul, Sanjoy K., et al.. (2017). Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data. Seminars in Arthritis and Rheumatism. 47(4). 478–484. 17 indexed citations

Broder, Michael S., Khaled Sarsour, Eunice Chang, et al.. (2016). Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis. Seminars in Arthritis and Rheumatism. 46(2). 246–252. 78 indexed citations

10.

Wilson, Jessica C., Khaled Sarsour, Neil Collinson, et al.. (2016). Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case–control analysis. Seminars in Arthritis and Rheumatism. 46(6). 819–827. 81 indexed citations

11.

Wilson, Jessica C., Khaled Sarsour, Neil Collinson, et al.. (2016). Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis. Seminars in Arthritis and Rheumatism. 46(5). 650–656. 47 indexed citations

12.

Gilden, Daniel, Joanna Kubisiak, Khaled Sarsour, & Craig Hunter. (2015). Diagnostic Pathways to Alzheimer Disease. Alzheimer Disease & Associated Disorders. 29(4). 330–337. 11 indexed citations

13.

Gaugler, Joseph E., Martha Hovater, David L. Roth, et al.. (2013). Depressive, functional status, and neuropsychiatric symptom trajectories before an Alzheimer's disease diagnosis. Aging & Mental Health. 18(1). 110–116. 11 indexed citations

14.

Grundman, Michael, Michael J. Pontecorvo, Stephen Salloway, et al.. (2012). Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline. Alzheimer Disease & Associated Disorders. 27(1). 4–15. 93 indexed citations

15.

Gaugler, Joseph E., Martha Hovater, David L. Roth, et al.. (2012). Analysis of Cognitive, Functional, Health Service Use, and Cost Trajectories Prior to and Following Memory Loss. The Journals of Gerontology Series B. 68(4). 562–567. 17 indexed citations

16.

Dennehy, Ellen B., Kristin Kahle‐Wrobleski, Khaled Sarsour, & Denái R. Milton. (2012). Derivation of a brief measure of agitation and aggression in Alzheimer's disease. International Journal of Geriatric Psychiatry. 28(2). 182–189. 9 indexed citations

17.

Classi, Peter, Denái R. Milton, Sarah A. Ward, Khaled Sarsour, & Joseph A. Johnston. (2012). Social and emotional difficulties in children with ADHD and the impact on school attendance and healthcare utilization. Child and Adolescent Psychiatry and Mental Health. 6(1). 33–33. 70 indexed citations

18.

Gaugler, Joseph E., Melanie M. Wall, Robert L Kane, et al.. (2011). Does Caregiver Burden Mediate the Effects of Behavioral Disturbances on Nursing Home Admission?. American Journal of Geriatric Psychiatry. 19(6). 497–506. 46 indexed citations

19.

Gaugler, Joseph E., Melanie M. Wall, Robert L Kane, et al.. (2010). The Effects of Incident and Persistent Behavioral Problems on Change in Caregiver Burden and Nursing Home Admission of Persons With Dementia. Medical Care. 48(10). 875–883. 55 indexed citations

20.

Sarsour, Khaled, Charles M. Morin, Kathleen A. Foley, Anupama Kalsekar, & James K. Walsh. (2009). Association of insomnia severity and comorbid medical and psychiatric disorders in a health plan-based sample: Insomnia severity and comorbidities. Sleep Medicine. 11(1). 69–74. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact